PLX

Protalix BioTherapeutics, Inc. [PLX] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

PLX Stock Summary

Top 10 Correlated ETFs

PLX


Top 10 Correlated Stocks

PLX


In the News

PLX Financial details

Company Rating
-
Market Cap
86.2M
Income
8.31M
Revenue
65.49M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
208
Optionable
No
Shortable
Yes
Earnings
02 May 2024
P/E
11.85
Forward P/E
-
PEG
-0.84
P/S
2
P/B
3.29
P/C
-
P/FCF
-14.7
Quick Ratio
1.15
Current Ratio
1.67
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.13
EPS next Y
-
EPS next Q
-
EPS this Y
-138.71%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
3.67%
Revenue Q/Q
1.36%
EPS Q/Q
223.44%
-
-
-
-
SMA20
-18.15%
SMA50
-13.62%
SMA100
14.69%
Inst Own
-
Inst Trans
-
ROA
12%
ROE
63%
ROC
0.31%
Gross Margin
74%
Oper. Margin
21%
Profit Margin
17%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.17-3.55
52W High
-44.33%
52W Low
+67%
RSI
30.94
Rel Volume
3.01
Avg Volume
341.3K
Volume
1.03M
Perf Week
-41.2%
Perf Month
-35.77%
Perf Quarter
-1.18%
Perf Half Y
34.68%
-
-
-
-
Beta
0.889
-
-
Volatility
0.44%, 0.48%
Prev Close
0%
Price
1.67
Change
0.6%

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap